What are the next steps for a patient with an abnormal Pap (Papanicolau) smear and a negative colposcopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

If you have an abnormal Pap test but a negative colposcopy, the next steps typically involve follow-up testing rather than immediate treatment, with a recommended repeat Pap test in 6-12 months or HPV testing at 12 months. This approach is based on the understanding that many mild cervical cell changes resolve on their own as the immune system clears the HPV infection that typically causes these changes 1. The management strategy should prioritize minimizing overtreatment while ensuring that any persistent or progressive abnormalities are detected and treated early.

Key Considerations for Follow-Up

  • For low-grade abnormalities (like ASCUS or LSIL), a 12-month follow-up is usually recommended, while for higher-grade abnormalities (like HSIL), a 6-month follow-up may be advised 1.
  • HPV testing might also be performed alongside the repeat Pap test, as it has been shown to have high sensitivity for identifying women with CIN II or III 1.
  • If follow-up tests remain abnormal, the healthcare provider may recommend another colposcopy to further evaluate the cervical tissue.

Rationale for Follow-Up Approach

The discrepancy between an abnormal Pap and normal colposcopy can occur because colposcopy may miss small lesions or because the abnormal cells detected on the Pap test were shed from an area not easily visible during colposcopy. Therefore, consistent monitoring through follow-up testing is crucial to ensure that any persistent or progressive abnormalities can be detected and treated early, thus preventing the development of cervical cancer.

Management of Biopsy-Confirmed CIN-1

For women with biopsy-confirmed CIN-1 and a satisfactory colposcopic examination, follow-up with repeat cervical cytology at 6 and 12 months or HPV DNA testing for high-risk types of HPV at 12 months is the preferred management approach 1. Treatment options, including cryotherapy, electrofulguration, laser ablation, cold coagulation, and LEEP, may be considered based on patient and provider preferences, especially if the abnormality persists or progresses.

From the Research

Abnormal Pap Smear with Colposcopy Negative: Next Steps

  • If a patient has an abnormal Pap smear but a colposcopy result is negative, the next steps may involve further testing and follow-up, as the risk of underlying high-grade lesions cannot be entirely ruled out 2.
  • A study published in 2021 suggested that all women testing positive for HPV, regardless of their Pap smear result, should be referred to colposcopy, highlighting the importance of HPV testing in cervical cancer screening 2.
  • The degree of agreement between HPV testing, Pap smear, and colposcopy in cervical dysplasia diagnosis has been found to be fair, indicating that these methods can provide complementary information for diagnosis and management 3.
  • Nonadherence to follow-up treatment of an abnormal Pap smear can be a significant issue, and addressing individual illness explanatory models may be crucial in motivating women to follow through with recommended treatment protocols 4.
  • Comparison of conventional Pap smear test, liquid-based cytology, and human papillomavirus testing as stand-alone or cotesting strategies for cervical cancer screening has shown that HPV stand-alone screening may offer a better balance of benefits and harms than cotesting 5.

Considerations for Next Steps

  • Repeat HPV testing may be considered for women with a positive HPV test but negative colposcopy, as some cases of high-grade squamous intraepithelial lesion (HSIL) may be diagnosed after the second HPV test 2.
  • The choice of screening strategy (stand-alone HPV testing vs. cotesting) should be based on individual risk factors, screening history, and patient preferences, taking into account the potential benefits and harms of each approach 5.
  • Patient education and counseling are essential to ensure adherence to follow-up treatment and screening recommendations, addressing any concerns or misconceptions that may impact health and illness behavior 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2012

Research

Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.